Eledon Pharmaceuticals, Inc. (ELDN) Operating cash flow 2016–2025
Eledon Pharmaceuticals, Inc. (ELDN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$62.3MFY2025 · since FY2016: -$4.9M → -$62.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$62.3M | -31.9% |
| FY2024 | -$47.3M | -19.6% |
| FY2023 | -$39.5M | -39.1% |
| FY2022 | -$28.4M | +1.7% |
| FY2021 | -$28.9M | -90.1% |
| FY2020 | -$15.2M | -9.8% |
| FY2019 | -$13.9M | -16.5% |
| FY2018 | -$11.9M | +20.4% |
| FY2017 | -$14.9M | -203.5% |
| FY2016 | -$4.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ELDN financial trends
ELDN RevenueELDN Net incomeELDN Net marginELDN Gross profitELDN Gross marginELDN Operating incomeELDN Operating marginELDN Free cash flowELDN Capital expendituresELDN Return on equityELDN Stock buybacksELDN Dividends paidELDN Total assetsELDN Total liabilitiesELDN Shareholders’ equityELDN overview →